Beijing Cancer hospital ( Site 1200)

Beijing, Beijing Municipality 100142

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Richter Transformation Lymphoma

Studies at this site

• A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006) — Running, not enrolling